Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2004;95:225-227
doi: 10.1161/01.RES.0000139434.26969.4f
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hasenfuss, G.
Right arrow Articles by Schillinger, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hasenfuss, G.
Right arrow Articles by Schillinger, W.
(Circulation Research. 2004;95:225.)
© 2004 American Heart Association, Inc.


Editorials

Is Modulation of Sodium-Calcium Exchange a Therapeutic Option in Heart Failure?

Gerd Hasenfuss, Wolfgang Schillinger

From the Georg-August Universität Göttingen, Herzzentrum, Kardiologie und Pneumologie, Göttingen, Germany.

Correspondence to Gerd Hasenfuss, MD, Georg-August-Universität Göttingen, Herzzentrum, Kardiologie und Pneumologie, Robert-Koch-Str. 40, 37099 Göttingen, Germany. E-mail hasenfus@med.uni-goettingen.de


Key Words: Na+-Ca2+ exchange • calcium • XIP • heart failure • SR function


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Besides the sarcoplasmic reticulum (SR) Ca2+-ATPase (SERCA), the sarcolemmal Na+-Ca2+ exchanger (NCX) is the most important Ca2+ transport protein responsible for maintaining the Ca2+ balance of the myocyte. It catalyzes the transport of Ca2+ across the membrane in exchange for Na+ in a reversible manner. Its activity is called "forward" when Na+ is transported inward and Ca2+ outward and "reversed" when ions are transported in the opposite directions. The driving force of NCX depends on Na+ and Ca2+ concentrations at either side of the plasma membrane and on the membrane potential. NCX is electrogenic and carries inward (depolarizing) current in forward mode and outward (repolarizing) current in reversed mode.1 NCX consists of 9 transmembrane helices and a large cytoplasmic loop. This loop has been shown to contain Ca2+- and Na+-binding regulatory sites, which are distinct from the transport sites. Thus, Na+ and Ca2+ ions are both transport substrates and modulators of activity. At the N-terminal end of the cytoplasmic loop near the membrane-lipid interface, there is a 20-amino acid segment, designated the endogenous XIP region. This region is considered to function as an autoinhibitory domain that plays a central role in NCX regulation. In addition, PIP2, protons, ATP, and PKC-dependent effects regulate NCX activity.1–3 More recently, it was shown that the Ca2+ binding protein sorcin exerts stimulatory actions on NCX.4

Altered expression and activity of the sarcolemmal NCX may play a key role for disturbed contractile function and arrhythmogenesis in hypertrophy and heart failure. It . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K.-O. Larsen, I. Sjaastad, A. Svindland, K. A. Krobert, O. H. Skjonsberg, and G. Christensen
Alveolar hypoxia induces left ventricular diastolic dysfunction and reduces phosphorylation of phospholamban in mice
Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H507 - H516.
[Abstract] [Full Text] [PDF]